Replies to post #778066 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Why state it differently when you said it so well?

Regulatory extensions coalesce around the data that’s actually working, in practice, not just in protocol.

:)

[Margin Buu]

Beautiful!

[sukus]

Slave,

You said it well. What we thought is delay, actually strategic. You are right, imagine if Nwbo got approval a day too early before SI 87 was in force? We thought as a big win but actually a huge huge loss. SI 87 changed all that equations. SI 87 is a blessing to innovations. Innovations can move fast. Regulatory red tape is no longer a huge hurdle. SI 87 also levels the playing fields. Previously, only those with big budget can move along. Today even small companies with limited budget can play too if the results is that good.
On top all of that, SI 87 is absolutely great for the patients, their Doctors, hospitals, and UK.

[StockFollower]

Slave1 -thank you for all your incredible insights. Could NWBO be utilizing the Flaskworks system to manufacture DCvax? Or is that system still a ways off? What implications does all this have for US approval? How does DCvax Direct come into play in the UK under SI 87?

What implications does this have on NWBO's revenue generation?

Thank you in advance for your insights!

SF